| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.27 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |